Wedbush is out with its report today on DemandTec DMAN, lowering its PT from $13 to $12.
In a note to clients, Wedbush writes, "As DMAN shares are trading at a relatively high EV/Sales multiple with only ~10-13% organic revenue growth, we believe the shares could be modestly overvalued at the current level; lowering target to $12."
Wedbush maintains Neutral on DMAN.
Shares of DMAN closed Thursday at $13.16, down 0.60% from Wednesday's close.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in